Active ingredient
Sodium Zirconium Cyclosilicate
4 finished FDA listings contain Sodium Zirconium Cyclosilicate as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- SODIUM ZIRCONIUM CYCLOSILICATE
- Dosage forms
- Powder, For Suspension
- Routes
- Oral
- Manufacturers / labelers
- 2
- Strengths listed
- 10 g/10g · 5 g/5g
- Brand names in FDA listings
- Lokelma
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2047628
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 207078 | ASTRAZENECA | 2018-05-18 | 4 |
Official labeling on DailyMed
- LOKELMA (SODIUM ZIRCONIUM CYCLOSILICATE) POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS] · version 8 · 2026-03-27
- LOKELMA (SODIUM ZIRCONIUM CYCLOSILICATE) POWDER, FOR SUSPENSION [ASTRAZENECA PHARMACEUTICALS LP] · version 28 · 2025-02-13
- LOKELMA (SODIUM ZIRCONIUM CYCLOSILICATE) POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS] · version 1 · 2023-06-01
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.